Proteome Sciences Plc ("Proteome Sciences" or "the Company")
Extension of Option Exercise Period
The Remuneration Committee and the Board of Proteome Sciences have today
resolved to extend the exercise period for an option over 433,124 Ordinary
Shares of 1p each in the Company which was granted to Christopher Pearce, Chief
Executive Officer, in March 2000 and which is due to expire on 20 April 2007.
The option cannot at present be exercised as the Company is currently in a
close period.
The Board has therefore extended the exercise period for these options for a
period of one month from the end of the close period. The terms of the option
remain otherwise unchanged.
Enquiries
Proteome Sciences plc
Christopher Pearce, Chief Executive Officer
Email: christopher.pearce@proteomics.com
James Malthouse, Finance Director
Email: james.malthouse@proteomics.com
Tel: +44 (0)1932 865065
Public Relations for Proteome Sciences
IKON Associates
Adrian Shaw
Tel: +44 (0)1483 535102
Mobile: +44 (0)797 9900733
Email: adrian@ikonassociates.com
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.